Medifoxamine: Difference between revisions
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
m Protected "Medifoxamine": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 19: | Line 19: | ||
| routes_of_administration= | | routes_of_administration= | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
== Overview == | |||
'''Medifoxamine''' is an [[antidepressant]] drug which inhibits the reuptake of [[dopamine]]<ref>Saleh S, Turner P. Ocular hypotensive effects of medifoxamine. ''British Journal of Clinical Pharmacology''. 1992 Sep;34(3):269-71. PMID 1389953</ref> and acts as an [[agonist]] at the [[5-HT2A receptor|5HT<sub>2A</sub>]] and [[5-HT2C receptor|5HT<sub>2C</sub>]] receptors.<ref>Martin P, Lemonnier F. The role of type 2 serotonin receptors, 5-HT2A and 5-HT2C, in depressive disorders: effect of medifoxamine. (French) ''L'Encephale''. 1994 Jul-Aug;20(4):427-35. PMID 7988407</ref> It is used mainly in [[France]].<ref>Mitchell PB. Novel French antidepressants not available in the United States. ''Psychopharmacology Bulletin''. 1995;31(3):509-19. PMID 8668756</ref> | '''Medifoxamine''' is an [[antidepressant]] drug which inhibits the reuptake of [[dopamine]]<ref>Saleh S, Turner P. Ocular hypotensive effects of medifoxamine. ''British Journal of Clinical Pharmacology''. 1992 Sep;34(3):269-71. PMID 1389953</ref> and acts as an [[agonist]] at the [[5-HT2A receptor|5HT<sub>2A</sub>]] and [[5-HT2C receptor|5HT<sub>2C</sub>]] receptors.<ref>Martin P, Lemonnier F. The role of type 2 serotonin receptors, 5-HT2A and 5-HT2C, in depressive disorders: effect of medifoxamine. (French) ''L'Encephale''. 1994 Jul-Aug;20(4):427-35. PMID 7988407</ref> It is used mainly in [[France]].<ref>Mitchell PB. Novel French antidepressants not available in the United States. ''Psychopharmacology Bulletin''. 1995;31(3):509-19. PMID 8668756</ref> | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
[[Category:Drug]] | |||
[[Category:Bicyclic antidepressants]] | [[Category:Bicyclic antidepressants]] | ||
Latest revision as of 16:39, 20 August 2015
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C16H19NO2 |
Molar mass | 257.328 g/mol |
3D model (JSmol) | |
|
WikiDoc Resources for Medifoxamine |
Articles |
---|
Most recent articles on Medifoxamine Most cited articles on Medifoxamine |
Media |
Powerpoint slides on Medifoxamine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Medifoxamine at Clinical Trials.gov Clinical Trials on Medifoxamine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Medifoxamine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Medifoxamine Discussion groups on Medifoxamine Patient Handouts on Medifoxamine Directions to Hospitals Treating Medifoxamine Risk calculators and risk factors for Medifoxamine
|
Healthcare Provider Resources |
Causes & Risk Factors for Medifoxamine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medifoxamine is an antidepressant drug which inhibits the reuptake of dopamine[1] and acts as an agonist at the 5HT2A and 5HT2C receptors.[2] It is used mainly in France.[3]
References
- ↑ Saleh S, Turner P. Ocular hypotensive effects of medifoxamine. British Journal of Clinical Pharmacology. 1992 Sep;34(3):269-71. PMID 1389953
- ↑ Martin P, Lemonnier F. The role of type 2 serotonin receptors, 5-HT2A and 5-HT2C, in depressive disorders: effect of medifoxamine. (French) L'Encephale. 1994 Jul-Aug;20(4):427-35. PMID 7988407
- ↑ Mitchell PB. Novel French antidepressants not available in the United States. Psychopharmacology Bulletin. 1995;31(3):509-19. PMID 8668756
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Bicyclic antidepressants